Novocure Limited Earnings

Novocure Limited’s revenue jumped 11.91% since last year same period to $154.99Mn in the Q1 2025. On a quarterly growth basis, Novocure Limited has generated -3.89% fall in its revenue since last 3-months.

Novocure Limited’s net profit jumped 11.46% since last year same period to $-34.32Mn in the Q1 2025. On a quarterly growth basis, Novocure Limited has generated 47.94% jump in its net profits since last 3-months.

Novocure Limited’s net profit margin jumped 20.88% since last year same period to -22.14% in the Q1 2025. On a quarterly growth basis, Novocure Limited has generated 45.83% jump in its net profit margins since last 3-months.

Novocure Limited’s earning per share (EPS) estimates for the current quarter stand at -0.46 - a -34.69% fall from last quarter’s estimates.

Novocure Limited’s earning per share (EPS) estimates for the current year stand at -0.46.

Novocure Limited’s earning per share (EPS) jumped 13.89% since last year same period to -0.31 in the Q1 2025. This indicates that the Novocure Limited has generated 13.89% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Novocure Limited’s return on assets (ROA) stands at -0.09.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Novocure Limited’s return on equity (ROE) stands at -0.46.